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INTRODUCTION 
•Responsible for significant morbidity in children and healthcare expenditures.  
•Few studies exist specifically addressing the clinical and epidemiologic characterization 
and management of DNI's in the pediatric population.  
•Descriptive study of the management of DNI in our institution  
•Demographic characteristics, clinical presentation, diagnostic and therapeutic 
approaches of DNI in pediatric patients.  
OBJECTIVE: 
DEEP NECK INFECTIONS (DNI’s)  
METHODS 
 



















Approval by the Ethical Committee of Hospital de Braga 
Retrospective Review 
Medical records of patients, aged up to 18 years 
Admitted for DNI at our department 
january 2011- august 2016 
DNI were divided into peritonsillar, parapharyngeal and 
retropharyngeal abscesses/ cellulitis 
METHODS 
Table 1. Data collected for each patient admitted for DNI, from 2011-2015   
Age at the admission (years) 
Gender 
Hospital Length of stay (HLS) (days) 
HLS superior to 5 days (HLS>5d), (days) 
Seasonal Distribution ( Winter, Spring, Summer, Autumn) 
Month at the admission 
Year at the admission 
Type of DNI (peritonsillar, parapharyngeal, retropharyngeal 
abscess/cellulitis) 
Side of DNI ( Left, Right, Bilateral) 
Etiology of the Abscess/cellulitis 
Symptoms at presentation 
Time since the beginning of symptoms until admission (days) 
Tonsillar Hypertrophy (Friedman Grading Scale) at the admission 
History of previous DNI 
Site and side of previous DNI 
History of Recurrent Tonsillitis 
Comorbidities 
Pre- hospital antibiotherapy treatment 
Performance of a Computed Tomography (CT) scan at the 
admission 
Dimension of the abscess in CT scan (mm) (greater axis) 
Performance of incision and drainage 
Performance of drainage in the operative room 
Laboratorial measurements at admission (Leucocyte / 
Neutrophil counts , C reactive protein) 
Microbiology analysis of DNI 
Antibiotherapy during hospital stay 
Transference to the hospital of local residency 
Occurrence of complications during hospital stay 
Need for surgical reintervention 
Need for antibiotherapy adjustment during hospital stay 




•IBM SPSS Statistics program, 22nd version 
•Descriptive statistics: mean ± standard deviation (SD) 
•Correlation (Pearson or Spearman correlation tests) 
• Associations for categorical variables (Chi-square or Fisher's exact tests) 
•Comparison between groups (t-tests or ANOVA and Mann-Whitney or Kruskal Wallis) 
•Post-hoc tests   
•For significant findings, the effect size is also reported. 
•Regression analysis to identify significant predictors of: 
Occurrence of complications after admission  
 Hospital length of stay 
•Significance is settled for p<0.05 
STATISTICAL ANALYSIS 
RESULTS 
Table 2. Demographic features of pediatric patients admitted for DNI, from 2011-2015 (n=98) 
Age (years) 12,07 (±4,75) 
Gender 
   Female 




HLS (days), (n=85) a 4,41 (±1,65) 
HLS>5d (days), (n=85) a 8 (9,6%) 
Seasonal Distribution 
   Winter 
   Spring 
   Summer 






Month, at the admission 
January- 5 (5,1%) 
February - 5 (5,1%) 
March- 9 (9,2%) 
April- 7 (7,1%) 
May-11 (11,2%) 
June- 11 (11,2%) 
July-17 (17,3%) 
August- 6 (6,1%) 
September- 8 (8,2%) 
October- 3 (3,1%) 
November- 7 (7,1%) 
December- 9 (9,2%) 
Year of Hospital Admission 
   2011 
   2012 
   2013 
   2014 
   2015 








a 15 patients transferred to the hospital of local residency were excluded 
sustained increase in the hospital 
admissions until 2015 
RESULTS 
Table 3. Clinical characterization of DNI in pediatric patients admitted, according to DNI subtype, from 2011-2015 

























AC+ Clindamycin- 50 
Clarithromycin + Clindamycin- 1  
AC- 3 
Ceftriaxone + Clindamycin- 3 












AC + Clindamycin- 3 












AC + Clindamycin- 2  












1  (6,7%) 
AC + Clindamycin- 14 





Right AC + Clindamycin 
p- value p<0.05 p>0,05 p>0,05 p<0.05 p<0.05 
a 15 patients transferred to the hospital of local residency were excluded 
RESULTS 
Table 4. Clinical features of pediatric patients admitted for DNI, from 2011-2015  (n=98) 





12(12,4%)  (Peritonsillar celullitis-2; Peritonsillar Abscess – 10) 













9 (9,3%)  
89 (90,7%) 

























Table 5. Clinical features of pediatric patients admitted for DNI, from 2011-2015 (n=98) 
CT scan at the admission 
   Yes 




Dimension of Abscess in CT scan (mm) (n=18) 
(greater axis) 
19,47(± 8,45) 
Incision and drainage (n=81) b  
   Yes 72(88,9%) 
Drainage in the operative room (n=81) b  
   Yes 
 
20(24,7%) 
Antibiotics during hospitalization (n=85) a 
AC 
Clarithromycin + Clindamycin 
AC + Clindamycin 
Ceftriaxone + Clindamycin 







a 15 patients transfered to the hospital of local residency were excluded 
b Patients with peritonsillar cellulitis were excluded 
Only 2 patients developed complications during hospital stay.  
 
A 4-year-old boy, admitted for a peritonsillar abscess for conservative treatment, initiated dyspnea with stridor 
in the first day in the ward and a quinsy tonsillectomy was performed. 
 
One patient was readmitted due to persistence of a peritonsillar abscess; It was the case of a 11-year-old boy, 
submitted to incision and drainage of the abscess, followed by 4days inpatient treatment with amoxicillin-
clavulanate plus clindamycin with clinical improvement. He was readmitted 6 days after, due to worsening of the 
symtoms and completed a 5-day-treatment with ceftriaxone plus metronidazole, with complete resolution.  
RESULTS- COMPLICATIONS 
RESULTS 
Table 6. Laboratorial and culture analysis of pediatric patients admitted for DNI, from 2011-2015 
Laboratorial measurements at admission 
    Leucocyte count  (x109 cells/L) (n=58) 
    Neutrophil count  (x109 cells/L) (n=57) 





Microbiology analysis of DNI (n=26) 
   Monomicrobial infections 
   Polymicrobial infections 
 
15 (61,5%)  
11 (38,5%) 
Microbiology analysis of DNI (n=26)  c 
  Streptococcus pyogenes  
  Streptococcus mitis 
  Staphylococcus aureus 
  Streptococcus gordonii 
  Streptococcus spp 
               Streptococcus intermedius 
  Streptococcus anginosus 
  Streptococcus constellatus 
  Aerococcus spp 
  Streptococcus Paransanguinis 
Anaerobic Bacteria 
   Fusobacterium 
   Veilonella 
   Prevotella melaninogenica 
   Peptostreptococcus asaccharolyticus 


















c The total percentage is superior to 100% due to polymicrobial infections 
RESULTS- Hospital Length of Stay (HLS) 
Patients with retropharyngeal 
abscess (5,25± 1,71) presented 
the highest HLS 
DNI (χ2 (3)=10,34, p=0,016) 
Mann Whitney test for all pair of groups 
≠Peritonsillar and retropharyngeal abscesses 
(Z(U)=5,00; p=0,017) 
≠ Peritonsillar abscess and cellulitis 
(Z(U)=215,50; p=0,022)  
≠ Retropharyngeal abscess and peritonsillar 
cellulitis (Z(U)=2,00; p=0,025) 
Comparison between categorical variables 
(Kruskal walis) 
RESULTS- Hospital Length of Stay (HLS) 
Table 7- Comparison of the HLS among  groups, in days. (n=70) 
Occurrence of complications 
   Yes 
   No 
 
8,50 ± 0,71 
3,81  ±  1,69 
p<0.05 
a 15 patients transferred to another hospital were excluded 
The HLS was positively associated with the 
occurrence of complications during the hospital 
stay (p<0,05). 
All the patients that presented complications 
also displayed a HLS>5d.  
(Z(U)=2,00; p=0,015). 
RESULTS- Hospital Length of Stay (HLS) 
The HLS has fair-moderate positive 
CORRELATION with the 
DIMENSION OF THE ABSCESS IN 
THE CT scan at the admission  
(r= 0,52, p<0,05, n=16) 
NOTE:  
There were no differences in the LHS between 
the patients submitted to drainage of abscess 
and the patients submitted to medical 
treatment alone (p>,0,05). 
RESULTS- DIMENSION OF THE ABSCESS 
Table 8. Comparison of the Dimension of the abscess in the CT scan at the admission among  groups 
History of previous recurrent tonsillitis Dimension of the abscess in the CT scan (greater axis) (mm) P value 
Yes 
No 
22,80  (± 7,33)  
15,33  (± 5,16) 
0,047 




22,42  (± 6,78)  
12,75  (± 3,69) 
 
0,018 
The group with RECURRENT TONSILLITIS presented  larger 
abscesses in the CT scan (p<0,05). 
The GROUP SUBMITTED TO DRAINAGE of abscess at the admission 
presented larger abscesses in the CT at admission (p<0,05). 
RESULTS 





•As expected, age of the patient at 
presentation was statistically significantly 
lower in the group patients submitted to 
drainage of the abscess in the operative room 
(Z(U)=94,0; p<0,001) 
Age 
RESULTS- REGRESSION ANALYSIS 
For the purpose of this study, NO significant regression models were obtained where 
Type of DNI 
Age 
Gender 
Time since the beginning of symptoms until admission  
Dimension of the abscess in CT scan (mm) (greater axis) 
Performance of incision and drainage 
 
were predictive variables for 
Occurrence of complications after admission  
 Hospital length of stay 
 
DISCUSSION 
•Few studies exist specifically addressing the INCIDENCE OF DNI in the pediatric population. 
•A decrease in the incidence has been previously observed  
  (improvements in antibiotics + better access to healthcare system)  
•Although recent reports have documented an INCREASE in this incidence. 
•This study revealed a SUSTAINED INCREASE in the hospital admissions due to DNI in the 
pediatric age, since 2011 
•Since 2012 a specific protocol for in-patient treatment of peritonsillar abscess has been instituted  
 >>leading to greater admissions of these cases. 
DISCUSSION 
There is NO ESTABLISHED GOLDSTANDARD treatment of DNI regarding : 
>> indications of surgical intervention, empirical choice and duration of antibiotic therapy. 
IN OUR HOSPITAL: 
>>Needle aspiration is performed in all patients in order to diagnose the DNI and followed, if positive for 
purulent exsudate, by INCISION and DRAINAGE procedures.  
>> intravenous Amoxicillin clavulanate + clindamycin is our initial empiric antibiotic therapy of choice 
>> Association of corticosteroids is the rule 
>> 5 days is the optimal duration of treatment (although earlier discharge is common) 
The INCISION and DRAINAGE approach is also commonly applied in the United Kingdom and Taiwan for 
peritonsillar abscess. 
•Mehanna HM, Bahnasawi LA, White A. National audit of the management of peritonsillar abscess. Postgrad Med J 2002;78:545–548 
•Wang YP, Wang MC,  Lin HC, Chou P. The impact of prior tonsillitis and treatment modality on the recurrence of peritonsillar abscess: a nationwide cohort study.PLoS One.2014; 
9(10): e109887. 
In this study, NO life-threatening complications were observed. 
•Retrospective design 
•Small sample size 
•Reflects the experience of single medical center 
•Empirical antimicrobial coverage may have affected microbiologic findings 




•Analysis of current management of pediatric DNI 
•Evaluation of the efficacy of a specific protocol  
•Low morbidity and rate of recurrence 
CONCLUSION 
•Prompt recognition and initiation of therapy is important to avoid serious 
complications.   
•Surgical incision and drainage followed by intravenous antibiotic and steroids proved 
to be successfull with low morbidity related to surgical approach.  
•However, in selected cases, medical therapy may be an alternative to surgical 
management in uncomplicated DNI.   
•Future research is crucial to determine appropriate guidelines to select the best 
therapeutic approach considering clinical, radiologic and laboratorial findings. 
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